Clinical Research Directory
Browse clinical research sites, groups, and studies.
National Cohort Study on Infant Gut Microbiota and Nutrition
Sponsor: DiproBio (Shanghai) Co., Ltd.
Summary
This study plans to collect 106,667 fecal samples from Chinese infants and children under 6 years old, with multi-dimensional stratification based on geographic location, mode of delivery, antibiotic exposure, and developmental stage. Fecal gut microbiota will be profiled to construct a gut microbiome atlas, establish quantitative analytical models linking geographic regions, physiological phenotypes and microbial signatures, and identify key microbial biomarkers associated with core healthy phenotypes.
Official title: Study on Gut Microbiota Characteristics and Their Relationship With Nutritional Health in Infants and Young Children Based on a National Cohort
Key Details
Gender
All
Age Range
0 Years - 6 Years
Study Type
OBSERVATIONAL
Enrollment
106667
Start Date
2026-04-30
Completion Date
2031-03-01
Last Updated
2026-07-15
Healthy Volunteers
Not specified
Conditions
Interventions
Fecal sample collection and gut microbiome profiling
This study is purely observational with no therapeutic or invasive clinical interventions implemented. We only collect non-invasive fecal specimens from enrolled healthy infants and children aged 0-6 years across China, perform microbial genome sequencing and microbial isolation culture to analyze gut microbiota characteristics, and construct a national pediatric gut microbiome atlas. No drugs, medical devices or clinical treatment adjustments are given to participants throughout the research.
Locations (1)
DiPROBIO(Shanghai) Co., Ltd.
Shanghai, China